✦ LIBER ✦

408 Phase 2 study of XL184 (BMS-907351) in a cohort of patients (pts) with hepatocellular carcinoma (HCC)

✍ Scribed by E. Van Cutsem; W.C. Su; J. Davis; N. Haas; T.A. Samuel; C.J. Tsao; T.S. Yang; H. Brandy; G. Mann; A. Cohn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

398 Phase 2 results of XL184 in a cohort

✍ H. Nechushtan; G. Edelman; G. Jerusalem; M. Gordon; H.M. Kluger; A. Moussa; I. R 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB

407 Phase 2 study of XL184 in a cohort o

✍ I. Vergote; A. Sella; C. Bedell; L. Ramondetta; G.I. Shapiro; K. Balic; E. Proko 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

397 Phase 2 results of XL184 in a cohort

✍ C. Yasenchak; K. Nackaerts; A. Awada; S.M. Gadgeel; B. Hellerstedt; M.C. Perry; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

406 Phase 2 study of XL184 in a cohort o

✍ D.C. Smith; A. Spira; J. De Grève; L. Hart; S. Holbrechts; C.C. Lin; M. Hussain; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

6617 Phase II study of NGR-hTNF, a selec

✍ Santoro, A.; Citterio, G.; Pressiani, T.; Gregorc, V.; Rimassa, L.; De Braud, F. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

42 Phase II study of BAY 43-9006 in pati

✍ G.K. Abou-Alfa; S. Ricci; D. Amadori; A. Santoro; A. Figer; J. De Greve; J. Doui 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 293 KB